Capacity Bio, Inc.

Capacity Bio, Inc.

 Capacity Bio is developing the most comprehensive and advanced mitophagy therapeutics and development platform for the purpose of restoring mitochondria quality control in disease. Market:Capacity Bio's lead focus is neurodegeneration and muscular disorders,...
CDR3 Therapeutics, Inc.

CDR3 Therapeutics, Inc.

CDR3 develops stem cell-based immunotherapies to cure HPV-related cancers using chimeric antigen receptors or chronic viral infections using T cell receptors. Market:Today, we lack cures for most virus-related cancers and chronic viral infections, especially from...
Dalton Bioanalytics

Dalton Bioanalytics

Dalton Bioanalytics’ Omni-MS platform analyzes nearly all major classes of bio-relevant molecules at a fraction of traditional multiomic costs. Market:Traditional multiomic analysis, the integrated analysis of proteins, lipids, electrolytes, small molecules, and so...
Eximius Diagnostics

Eximius Diagnostics

Eximius Diagnostics is developing extracellular vesicle (EV) based liquid biopsy tests for cancer diagnosis and treatment monitoring. Market:There are ~4.5 million patients in the US at high risk for Hepatocellular Carcinoma (HCC), and for whom the American...
Forcyte Biotechnologies, Inc.

Forcyte Biotechnologies, Inc.

Forcyte Biotechnologies, Inc. is the first company aiming to tackle diseases of cell mechanobiology by directly screening contractile cell force in an automation-friendly & high-throughput format. Market:Forcyte Biotechnologies, Inc. provides predictive disease models...